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A series of N-aryl and N-heteroaryl pyrazoles have been deproto-metallated using a 2,2,6,6-
tetramethylpiperidino-based mixed lithium-zinc combination. Mono-, di-, and tri-iodides have been 
obtained after subsequent trapping with iodine, depending on the substrate and on the quantity of 10 
base used. The results have been discussed in the light of the CH acidities of the substrates, 
determined both in the gas phase and in THF solution using the DFT B3LYP method.  
Introduction 
Pyrazoles belong to the most important heterocycles 
containing nitrogen. They have attracted considerable interest 15 
because of their long history of applications as 
pharmaceuticals and agrochemicals.1 Among them, N-aryl 
derivatives have been shown to exhibit a broad spectrum of 
biological activities.2  
 Lithium (or magnesium) monometal bases have been 20 
employed to perform deprotonative metallation reactions of 
pyrazoles bearing on nitrogen an aromatic ring, allowing their 
subsequent functionalization.3 Nevertheless, low temperatures 
are required to perform these reactions.4  
 In 2009, Knochel and co-workers showed that mixed 25 
lithium-magnesium bases such as TMPMgCl·LiCl and 
(TMP)2Mg·2LiCl (TMP = 2,2,6,6-tetramethylpiperidino) were 
suitable reagents to allow chemoselective reactions of SEM-
protected and N-methyl pyrazoles.5  
 In the search of new bimetallic combinations for deproto-30 
metallation purpose,6 we recently observed that the basic 
mixture obtained from ZnCl2·TMEDA (TMEDA = N,N,N',N'-
tetramethylethylenediamine) and LiTMP (3 equiv), which 
proved to be 1:1 LiTMP-(TMP)2Zn, could be used 
synergically to functionalize sensitive compounds such as 35 
functionalized or heterocyclic aromatics.7  
 In the continuation of this study, we here describe the use 
of this lithium-zinc base in N-aryl and N-heteroaryl pyrazole 
series. As an attempt to rationalize the regioselectivity of the 
reactions, the CH acidities in THF of the pyrazole substrates 40 
were calculated within the density functional theory (DFT) 
framework using homodesmic reaction approach described 
earlier.8 
Results and discussions 
Synthetic aspects 45 
Commercial 1-phenyl-1H-pyrazole could be deproto-
metallated upon treatment by 1:1 LiTMP-(TMP)2Zn (0.5 
equiv each) in tetrahydrofuran (THF) at room temperature for 
2 h to afford, after subsequent trapping with iodine, the 5-
substituted derivative in 56% yield.7a Even if not isolated, the 50 
5,2'-diiodinated derivative was also present on the crude.9 
This prompted us to replace the phenyl group at nitrogen with 
different aryl and heteroaryl groups to see the impact on the 
outcome of the reaction. 
 To this purpose, pyrazole was treated with aryl and 55 
heteroaryl halides (iodides, bromides, or even chlorides) 
under copper catalysis using the conditions reported by 
Cristau, Taillefer and co-workers,10 to afford the derivatives 
1a-q in moderate to high yields (Scheme 1). 
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Scheme 1 Copper-catalyzed N-arylation of pyrazole. 
 The behaviour of the pyrazoles 1a-h bearing a substituted 
phenyl group towards the lithium-zinc mixture was first 
studied (Table 1). As previously observed with 1-phenyl-1H-
pyrazole, the reaction of the 4'-tert-butylated derivative 1a 65 
with 1:1 LiTMP-(TMP)2Zn (0.5 equiv each) in THF for 2 h 
followed by trapping with iodine led to two derivatives, the 5-
substituted derivative 2a, obtained in 54% yield, and the 5,2'-
diiodide11 3a, isolated in 28% yield. The formation of the 
diiodide 3a was favoured (66%) by increasing the base 70 
quantity to 1 equiv (entry 1). 
 The behaviour of the pyrazole 1b bearing at nitrogen a 4-
(dimethylamino)phenyl group12 proved quite similar, giving 
either the monoiodide 2b as the main derivative (54% yield) 
using LiTMP-(TMP)2Zn (0.5 equiv each) or the diiodide 3b 75 
(67% yield) turning to a larger amount of base (entry 2). Both 
the mono- and the diiodide 2b and 3b were identified 
unequivocally by X-ray structure analysis. The iodide 2b was 
converted by Suzuki coupling to the corresponding phenyl 
derivative 4b in 73% yield, and the crystal structure of the 80 
latter was also obtained (Figure 1).† 
 No reaction was observed starting from the 4-nitrophenyl 
substituted pyrazole 1c (entry 3), probably due to competitive 
reaction of the base with the sensitive nitro group,13 but using 
 2 
other electron-withdrawing R groups the reactions proceeded 
satisfactorily. In the case of pyrazoles 1d (4-cyanophenyl 
substituted) and 1e (4-(trifluoromethyl)phenyl substituted), 
the 5,2'-diiodides 3d and 3e were already isolated in satisfying 
yields (65 and 84%, respectively) using 0.5 equiv of base 5 
(entries 4 and 5). The fluoro group proved to activate less 
strongly the 2' site than the cyano and trifluoromethyl groups, 
giving 3f in a moderate 31% yield using 0.5 equiv of base. 
Turning to 1 equiv of base led to the formation of the two 
diiodides 3f and 3'f, a result probably due to the strong ability 10 
of the fluoro group to direct the metallation to the ortho site 
(entry 6).14  
        
Figure 1 ORTEP diagrams (30% probability) of 2b (left), 3b (middle) 
and 4b (right). 15 
 With N-(4-methoxyphenyl)pyrazole (1g), we turned to an 
electron-donating group renowned for being less ortho-
directing than fluoro.15 Surprisingly, the corresponding 5,2'-
diiodide 3g was isolated in 60% yield using 0.5 equiv of base 
(entry 7). By moving the methoxy group from the 4' to the 3' 20 
position (substrate 1h), the diiodide 3h was formed in a 
similar 61% yield but the monoiodide 2h was concomitantly 
formed in 12% yield. A metallation occurring first at the 5 
position was evidenced using 0.33 equiv of base; under the 
same reaction conditions, the iodide 2h was obtained in 70% 25 
yield (entry 8). 
Table 1 Deprotonative metallation of 1a-h followed by trapping with I2 
N
N 1) (TMP)2Zn
(0.5 equiv)
+ LiTMP
(0.5 equiv)
THF, rt, 2 h
2) I2
1
R
N
N
2
R
N
N
3
R
N
N
3'
R
I I I
5
4'
2'
3'
I
I
 
Entry Substrate (R) Products, Yields (%) 
1 1a (4-tBu) 2a, 54 (4)a 3a, 28 (66)a -b 
2 1b (4-NMe2) 2b, 54 (0)a 3b, 28 (67)a -b 
3 1c (4-NO2) -c -c -c 
4 1d (4-CN) -b 3d, 65 -b 
5 1e (4-CF3) -b 3e, 84 -b 
6 1f (4-F) -b 3f, 31 (57)a 3'f, 0 (22)a 
7 1g (4-OMe) -b 3g, 60 -b 
8 1h (3-OMe) 2h, 12 (70)d 3h, 61 (7)d -b 
a
 The deprotonation was performed using (TMP)2Zn (1 equiv) + LiTMP 
(1 equiv). b Not obtained. c No reaction. d The deprotonation was 30 
performed using (TMP)2Zn (0.33 equiv) + LiTMP (0.33 equiv). 
 A reaction pathway where the deprotonation proceeds with 
LiTMP, and the resultant aryllithium intermediate converts by 
in situ trapping with (TMP)2Zn (or ArZnTMP) to the more 
stabilized arylzinc species was assumed to explain the synergy 35 
of the metallation reactions using 1:1 LiTMP-(TMP)2Zn.7a To 
rationalize the dimetallation easily observed with the N-aryl 
pyrazoles involved in the reaction, one can consider a 
proximity effect either with a lithium pyrazolylzincate A or 
with a pre-metallation complex B between LiTMP and the 40 
pyrazole complexing nitrogen16 (Scheme 2). The products 
being always iodinated at their 5 position, intramolecular 
deprotonation reactions from the pyrazolylzincates A seem 
more likely. 
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Scheme 2 Proposed pathways for the dimetallation of N-aryl pyrazoles 
using 1:1 LiTMP-(TMP)2Zn. 
 In the search of other polymetallation reactions, we 
submitted 1,1'-(1,4-phenylene)bis(1H-pyrazole) (1i)17 to 
LiTMP-(TMP)2Zn (1 equiv each) in THF for 2 h before 50 
interception with iodine. Under these conditions, the triiodide 
5i was isolated in 61% yield. When 1,1'-(1,2-
phenylene)bis(1H-pyrazole) (1j) was similarly treated, the 
corresponding triiodide 5j was also obtained but in a lower 
37% yield. Indeed, a less iodinated derivative 6j resulting 55 
from a deprotonation at the 5 position of both pyrazole rings 
was also formed in 37% yield, and was identified 
unequivocally by X-ray structure analysis (Scheme 3, Figure 
2).† These results tend to show that the deprotonation at the 
phenylene ring is less favoured when the pyrazole ring does 60 
not belong to the same plane. 
 We then studied the behaviour of the pyrazoles 1k and 1l 
bearing a thiophenyl group (Scheme 4). Upon treatment by 
1:1 LiTMP-(TMP)2Zn (0.5 equiv each) followed by quenching 
with iodine, the N-thiophenyl pyrazole 1k provided both 65 
diiodides 8k and 8'k in 11 and 55% yield, respectively 
resulting from 5,3' and 5,5' dimetallation reactions. This result 
can be explained by the strong ability of sulphur to acidify the 
neighbouring hydrogen.3h In the case of 1l, the acidifying 
effects of sulphur and pyrazole combine to allow the 70 
formation of the monoiodide 7'l (30% yield) in addition to the 
 3 
diiodide 8l (41% yield, Figure 3†). Reducing the quantity of 
base to 0.33 equiv favoured the formation of 7'l, which was 
isolated in 62% yield. 
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Scheme 3 Deprotonative metallation of 1i and 1j followed by 5 
trapping with I2. 
  
Figure 2 ORTEP diagrams (30% probability) of 1j and 6j. 
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Scheme 4 Deprotonative metallation of 1k and 1l followed by 10 
trapping with I2. a The deprotonation was performed using (TMP)2Zn 
(0.33 equiv) + LiTMP (0.33 equiv).  
 
Figure 3 ORTEP diagrams (30% probability) of 8l. 
 The pyrazole 1m benefitting from a doubly activated 15 
position was next considered. However, whatever the quantity 
of base employed (0.33, 0.5 or 1 equiv), mixtures were 
obtained (Table 2). It was not possible to favour the formation 
of the monoiodide 7m by reducing the amount of base, nor the 
formation of one of the diiodides 8m or 8'm, but the triiodide 20 
9m was formed as the main product (48% yield, Figure 4†) 
employing 1 equiv of base. These results could be due to the 
long range acidifying effect of the chloro group,18 not only 
activating the ortho, but also the para site. 
Table 2 Deprotonative metallation of 1m followed by trapping with I2 25 
N
N 1) (TMP)2Zn
(x equiv)
+ LiTMP
(x equiv)
THF, rt, 2 h
2) I2
1m
N
N
N
7m: R = H
8m: R = I
N
N
N
8'm: R = H
9m: R = I
N
I I
5
3' 5'
ClCl
I
Cl
R R
 
Entry x Products, Yields (%) 
1 0.33 7m, 8 8m, 11 8'm, 26 9m,   0 
2 0.5 7m, 0 8m, 18 8'm, 34 9m, 12 
3 1 7m, 0 8m,   5 8'm,   9 9m, 48 
 
Figure 4 ORTEP diagrams (30% probability) of 9m. 
 Fewer derivatives are formed in the case of 1n which is 
symmetrical due to the removal of the chloro group. In 30 
addition to the 5-iodo derivative 7n, which was formed in 8% 
yield, the 5,3'-diiodide 8n was isolated in 60% yield (Table 3, 
entry 1, Figure 5†). The isomer 1o gave a mixture of two 
iodides where the pyridine ring was substituted at C2 (8o, 
28% yield, Figure 6†) and C4 (8'o, 30% yield) in a similar 35 
overall 58% yield (Table 3, entry 2).  
Table 3 Deprotonative metallation of 1n-q followed by trapping with I2 
N
N
1) (TMP)2Zn (0.5 equiv)
+ LiTMP (0.5 equiv)
THF, rt, 2 h
2) I2
1n-q
N
N
7
N
N
8/8'
I I
5
N(N) N(N) N(N)
I
 
Entry 1 x Products, Yields (%) 
1 1n 
N
3'
 
0.5 7n, 8 8n (3'-I), 60 
2 1o 
N
2'4'
 
0.5  8o (2'-I), 28 
8'o (4'-I), 30 
3 1p 
N3'
 
0.5 7p, 45 8p (3'-I), 14 
4 1 7p,   0 8p (3'-I), 49 
5 1q 
N N
 
0.5 7q, 60  
 The substrate 1p proved less prone to dideprotonation 
 4 
either because of only one pyridine position activated by the 
pyrazole nitrogen instead of two in the previous examples or 
because the pyrazole ring hardly belongs to the plane of the 
pyridine because of repulsion between nitrogens. Indeed, the 
monoiodide 7p was the main product (45% yield) under the 5 
conditions used before (Table 3, entry 3). Increasing the base 
quantity to 1 equiv led to the diiodide 8p in 49% yield (Table 
3, entry 4). Finally it was possible to obtain exclusively the 5-
iodo derivative 7q (60% yield) starting from the pyrimidin-2-
yl substituted pyrazole 1q (Table 3, entry 5). 10 
       
Figure 5 ORTEP diagrams (30% probability) of 1n (left), 7n (middle) 
and 8n (right). 
   
Figure 6 ORTEP diagrams (30% probability) of 1o and 8o. 15 
Computational aspects 
CH acidity of pyrazoles has been the subject of few studies. 
The value for 1-propyl-1H-pyrazole was experimentally 
found, and reported in 1985.19 Substituent-CH acidities for 
methylpyrazoles20 and ethynylpyrazoles21 were respectively 20 
evaluated in liquid NH3 and DMSO. In the last case, the 
results were proved by employing the semi-empirical CNDO 2 
method. In the present paper, the DFT calculations of CH 
acidity of the different N-aryl pyrazoles both in gas phase 
(Scheme 5) and in THF solution (Scheme 6) are presented. 25 
 The gas phase acidities acidG and pKa values in THF 
solution of all the pyrazole substrates were calculated using a 
theoretical approach related to the one previously described.8  
 All the calculations were carried out using the DFT B3LYP 
method. The geometries were optimized using the 6-31G(d) 30 
basis set. No symmetry constraints were imposed. In order to 
perform stationary points characterization and to calculate 
zero-point vibrational energies (ZPVE) and thermal 
corrections to Gibbs free energy, vibrational frequencies were 
calculated at the same level of theory. The single point energy 35 
calculations were performed using the 6-311+G(d,p) basis set. 
The gas phase Gibbs energies (G0298) were calculated for each 
species using the following equation: 
G0298 = E + ZPVE + H0298 – TS0298. 
 The gas phase acidities acidG were determined as the 40 
Gibbs energies of deprotonation of the substrates RH (RH(g)  R(g) + H+(g)) by the following formula: 
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Scheme 5 Gas phase acidities (acidG, kcalmol-1) of the investigated 
pyrazoles. 45 
acidG = G0298(R) + G0298(H+)  G0298(RH). 
 The solvent effects were evaluated using the polarized 
continuum model (PCM) with the default parameters for 
THF.22 The cavity was built up using a united atom (UA) 
model, applied on atomic radii of the UFF force field. The 50 
PCM energies EPCM were calculated at the B3LYP/6-
311+G(d,p) level using geometries optimized for isolated 
structures. The Gibbs energies in solution Gs were calculated 
for each species by the formula: 
Gs = G0298 + EPCM  E. 55 
 To cancel possible errors, the pKa values were calculated by 
means of the following homodesmic reaction: 
RH(s) + Het(s)  R(s) + HetH(s), 
where HetH is an appropriate five-membered heterocycle 
with experimentally known pKa value. In the present work, 1-60 
propyl-1H-pyrazole was chosen as reference compound since 
its pKa value in THF found by Fraser et al.,19 35.9, was 
supposed to be close to those for the investigated substrates. 
 The Gibbs energies of the homodesmic reactions were 
respectively calculated using the following equations: 65 
 5 
r s s s
products reactants
G G G     
r s
a a
1p (R - H) p (Het - H)
ln10
  GK K
RT
. 
 The CH acidity of side groups such as methoxy, 
dimethylamino and tert-butyl was expected to be significantly 
lower and hence was not considered. 5 
 It is obvious that some of the compounds under 
consideration exist in form of two or even more rotamers due 
to sterical interaction of adjacent hydrogens or/and 
heteroatom lone pairs. In such cases, the data on Schemes 5 
and 6 refer to the most stable rotamers. According to our 10 
calculations for the investigated pyrazoles, the favoured 
rotamer form was determined substantially by intermolecular 
interactions. 
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Scheme 6 Calculated values of pKa(THF) of the investigated pyrazoles. 15 
 For the pyrazoles bearing a 4-substituted phenyl group, an 
inequality in C-H acidity (up to 4 logarithmic units) between 
the C2' and C6' sites, as well as between the C3' and C5' sites, 
was noticed. This phenomenon could be explained by electron 
repulsion of syn-periplanar carbon and nitrogen lone pairs, 20 
and/or dipole moment direction. 
 Among the molecules with several rotamers, the 
pyridylpyrazoles are likely to exist in form with remote 
heteroatoms (nitrogens), while for the sulphur-containing 
compounds it is vice versa. For the para-bipyrazolyl 1i, anti- 25 
disposition of heterocycles is much more favorable than syn-, 
while for the ortho-bipyrazolyl 1j, the anti-form dominates 
over the amphi-, and the local minimum on the PES 
corresponding to the syn- form was not even located. 
 It is desirable to know the impact on the CH acidity of 30 
pyrazoles, and hence on their reactivity, of the electronic 
effects of substituents. This aim can be achieved by using the 
Hammett equation (or a similar approach), which is well-
known as a powerful tool for the prediction of many important 
physico-chemical characteristics of substances.23 Linear free 35 
energy relationship (LFER) methodology can also be used to 
study the electronic effects of the substituents on the CH 
acidity.  
 In a previous study8 the peculiarities concerned with the 
application of LFER methodology to heterocycles were 40 
briefly discussed. In this paper the heterocycle was considered 
to this purpose as a single system in which the substituent and 
the reaction centre interact. The main points of interest are (i, 
practical) the influence of the X substituent nature of N-
substituted pyrazoles on the pKa at the most acidic 5 position 45 
(Table 4, entries 1-9), and (ii, theoretical) the influence of the 
Y substituent nature of N-(4-substituted phenyl)pyrazoles on 
the pKa at the 2' position (Table 4, entries 10-17). The data 
show that there is a correlation between the nature (electron-
donating or electron-withdrawing) of the substituent X or Y 50 
and the pKa change.  
Table 4 Calculated pKa(THF) values for the pyrazoles and substituent 
constants23  
Entry Compound X or Y pKa(THF) m p F R 
1 
X
N
N5
 
 Ph 33.9 0.06 -0.01 0.12 -0.13 
2 1a 4-tBuC6H4 33.5 0.07 0.01 0.12 -0.11 
3 1c 4-O2NC6H4 28.8 0.25 0.26 0.26 0.00 
4 1f 4-FC6H4 32.2 0.12 0.06 0.17 -0.11 
5 1g 4-MeOC6H4 33.7 0.05 -0.08 0.13 -0.21 
6 1n pyridin-4-yl 31.0 0.27 0.44 0.21 0.23 
7 1o pyridin-3-yl 31.3 0.23 0.25 0.24 0.01 
8 1p pyridin-2-yl 35.0 0.33 0.17 0.40 -0.23 
9 1q pyrimidin-2-yl 34.0 0.23 0.53 0.13 0.40 
10 
N
N
Y
2'
 
 H 40.2 0.00 0.00 0.00 0.00 
11 1a tBu 40.2 -0.10 -0.20 -0.02 -0.18 
12 1b NMe2 41.7 -0.16 -0.83 0.15 -0.98 
13 1c NO2 31.9 0.71 0.78 0.65 0.13 
14 1d CN 33.5 0.56 0.66 0.51 0.15 
15 1e CF3 34.9 0.43 0.54 0.38 0.16 
16 1f F 35.9 0.34 0.06 0.45 -0.39 
17 1g OMe 38.9 0.12 -0.27 0.29 -0.56 
 
 Unfortunately, this study was restricted by lacking of data 55 
on LFER constants.23 As pure ortho-, meta- and para-
positions do not exist for five-membered rings, the Jaffe's 
approach was employed to describe the substituent effects in 
these “unconventional“ five-membered rings according to: 
Property = a1 + a2 m + a3 p (where ai – fitted constants). 60 
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 The best equation within the Jaffe's method for the most 
acidic 5 position of 1-phenyl-1H-pyrazole and the compounds 
1a, 1c, 1f, 1g, 1n and 1o is as follows (compounds 1p and 1q 
with strong steric interactions were excluded as outliers):  
pKa(THF) = 36.5 – 40.6 m + 12.5 p 5 
(N = 7, r2 = 0.911, rmse = 0.67) 
According to Swain and Lupton, the electronic effects of a 
substituent can be splitted into a field/inductive component 
(F) and a resonance component (R).23 The best equation for 
the same compounds within this approach is: 10 
pKa(THF) = 37.3 – 29.4 F – 0.3 R 
(N = 7, r2 = 0.902, rmse = 0.71) 
Thereby, among the considered methods, the Jaffe's method 
gives the best equations for CH acidity prediction. The 
influence of a substituent on forming carbanion center is more 15 
similar to that for meta-group in benzene ring: the inductive 
effects predominate over the resonance effects, a result in 
agreement with that found earlier for triazoles.8b 
 Concerning the CH acidity at the 2' position of the 
compounds 1a-g, the pyrazole was treated as an ordinary 20 
substituent. This led to an excellent correlation even under 
one-parametric formalism: 
pKa(THF) = 39.8 – 11.1 m 
(N = 8, r2 = 0.990, rmse = 0.38) 
The best equations within the Swain's and Jaffe's approaches 25 
proved to be respectively: 
pKa(THF) = 39.8 – 11.4 F – 3.7 R 
(N = 8, r2 = 0.994, rmse = 0.34) 
and 
pKa(THF) = 39.7 – 10.3 m – 0.5 p 30 
(N = 8, r2 = 0.991, rmse = 0.40) 
 So, the correlation between calculated and predicted pKa 
values of pyrazoles using LFER equations (Figure 7) gives the 
opportunity to predict their reactivity semi-quantitatively at 
low computational cost. 35 
Discussion 
The calculations show that the investigated N-aryl and N-
heteroaryl pyrazoles possess several deprotonation sites. 
Nevertheless, except when thiophen-3-yl and 2-chloropyridin-
4-yl are grafted on the pyrazole 1 position, the most acidic site 40 
corresponds to the 5 position of the pyrazole ring. When the 
gas phase and THF solution CH acidities of the pyrazoles are 
compared, a correlation can be easily found and the most 
acidic position remains the same. These results are in good 
agreement with the corresponding experimental data. Indeed, 45 
1-(thiophen-3-yl)-1H-pyrazole (1l) at least deproto-metallated 
at its most acidic C2' position, and all the other compounds 
studied are at least iodinated at C5. The exception is 1-(2-
chloropyridin-4-yl)-1H-pyrazole (1m), which is not 
predominantly functionalized at its most acidic site, a result 50 
that could be in relation with the size of both the base and the 
chloro group. 
 Compared with 1-phenyl-1H-pyrazole, the derivatives 
bearing a nitro, a cyano, a trifluoromethyl and, to a lesser 
extent, a fluoro group at the 4 position of the phenyl ring 55 
(compounds 1c-f) have a higher CH acidity in THF solution at 
C5; the tert-butyl and methoxy group (compounds 1a, 1g and 
1h) have nearly no effect, and the dimethylamino group 
(compound 1b) decreases this acidity (Scheme 6). Thus, 
according to calculations, electron-withdrawing groups are 60 
expected to favour the deprotonation on the pyrazole ring 
whereas the electron-donating should disfavour it. The 
experimental results are rather in accordance with these 
predictions since the compounds 1a,b behave as 1-phenyl-1H-
pyrazole, mainly leading to the 5-iodo derivatives, whereas 65 
diiodides are obtained starting from the compounds 1d-h 
(Table 1).  
 
Figure 7 Correlation between calculated and predicted pKa values of 
pyrazoles in THF solution using equations within Jaffe method for (a) 70 
Table 4, entries 1-7, and (b) Table 4, entries 10-17, and (c) regression of 
pKa(THF) versus m for Table 4, entries 10-17.  
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 It can also be deduced from the calculations that the CH 
acidity at C5 increases with the introduction of a pyridin-4-yl 
(compounds 1m and 1n), a pyridin-3-yl (compound 1o) and, 
to a lesser extent, a thiophen-2-yl group (compound 1k) on its 
1 position. No change is observed with a thiophen-3-yl group 5 
(compound 1l). In contrast, when a pyridin-2-yl (compound 
1p) or a pyrimidin-2-yl (compound 1q) is present, this acidity 
decreases, a result that could be in relation with the presence 
of the nitrogen(s) of these groups at a position close to the C5 
site (Scheme 6). Experimentally, diiodides are more easily 10 
obtained from the compounds 1m-o and 1k, which have a 
stronger CH acidity at C5, whereas monoiodides are formed 
as main products from the compounds 1p and 1q, which have 
a weaker CH acidity at C5 (compound 1h has an intermediate 
behaviour) (Table 2 and 3).  15 
 These results tend to show that metallation at C5 occurs 
first; second (and possibly third) metallation could then take 
place, according to the mechanism depicted in Scheme 2. 
Indeed, the second metallation does not necessarily takes 
place at the second most acidic position. One example is the 20 
reaction of 1-(4-fluorophenyl)-1H-pyrazole (1f) for which the 
second most acidic phenyl site is C3' and the main product the 
5,2'-diiodinated derivative 3f (Table 1, entry 6).  
Conclusions 
Attempts to rationalize the outcome of the deproto-metallation 25 
reactions of N-aryl and N-heteroaryl pyrazoles using the TMP-
based mixed lithium-zinc combination were performed using 
the CH acidities of the substrates in THF solution calculated 
using continuum solvation model. Even if the approach has 
limits, mainly due to the lack of mechanism information 30 
concerning such reactions, it proved efficient to predict in 
most cases studied the first deprotonation sites. In addition, 
the study carried out with N-(4-substituted phenyl) pyrazoles 
allowed both experimentally and theoretically the 
identification of a meta acidifying effect12 from groups such 35 
as cyano, trifluoromethyl, fluoro and methoxy.  
Experimental 
Syntheses: general methods 
Metallation reactions were performed under argon atmosphere. 
THF was distilled over sodium/benzophenone. Column 40 
chromatography separations were achieved on silica gel (40–63 m). Melting points were measured on a Kofler apparatus. IR 
spectra were taken on a Perkin-Elmer Spectrum 100 
spectrometer. 1H and 13C Nuclear Magnetic Resonance (NMR) 
spectra were recorded on a Bruker Avance III spectrometer at 300 45 
and 75 MHz, respectively. 1H chemical shifts () are given in 
ppm relative to the solvent residual peak, and 13C chemical shifts 
relative to the central peak of the solvent signal,24 and coupling 
constants (J) are given in Hz. Mass spectra (HRMS) 
measurements were performed at the CRMPO (Centre Régional 50 
de Mesures Physiques de l’Ouest) of Rennes using either a 
Waters Q-TOF 2 or a Bruker micrOTOF Q II instrument in 
positive elestrospray CI mode. 
1-[4-(tert-Butyl)phenyl]-1H-pyrazole (1a) was prepared from 1-
bromo-4-tert-butylbenzene using a described procedure10 55 
(reaction time: 115 h). Yield: 82%. Colourless liquid. IR (ATR): 
2962, 2905, 2867, 1524, 1394, 1034, 937, 836, 746 cm-1. 1H 
(CDCl3, 300 MHz) 1.40 (s, 9H), 6.49 (dd, 1H, J = 1.5 and 2.0), 
7.51 and 7.67 (AB, d, 4H, J = 8.8), 7.78 (d, 1H, J = 1.5), 7.94 (d, 
1H, J = 2.0). 13C (CDCl3, 75 MHz) 31.4 (3C), 34.6, 107.4, 119.0 60 
(2C), 126.3 (2C), 126.8, 137.9, 140.9, 149.6. These values are 
consistent with those reported in the literature.25 
1-[4-(Dimethylamino)phenyl]-1H-pyrazole (1b) was prepared 
from 1-bromo-4-(dimethylamino)benzene using a described 
procedure10 (reaction time: 115 h). Yield: 45%. White solid (mp = 65 
94 °C). IR (ATR): 1744, 1525, 1354, 1226, 936, 816, 754 cm-1. 
1H (CDCl3, 300 MHz) 2.98 (s, 6H), 6.41 (dd, 1H, J = 1.6 and 
2.3), 6.77 and 7.51 (AB, d, 4H, J = 9.1), 7.67 (d, 1H, J = 1.6), 
7.79 (d, 1H, J = 2.3). 13C (CDCl3, 75 MHz) 40.8 (2C), 106.8, 
112.8 (2C), 120.8 (2C), 126.7, 130.8, 140.2, 149.4. These values 70 
are consistent with those reported in the literature.26 
1-(4-Nitrophenyl)-1H-pyrazole (1c) was prepared from 1-
bromo-4-nitrobenzene using a described procedure10 (reaction 
time: 160 h). Yield: 42%. Yellow solid (mp = 174 °C). IR (ATR): 
1740, 1366, 1239, 1217, 1205, 749 cm-1. 1H (CDCl3, 300 MHz) 75 
6.55 (dd, 1H, J = 1.8 and 2.6), 7.79 (d, 1H, J = 1.8), 7.88 and 8.33 
(AB, d, 4H, J = 9.3), 8.04 (d, 1H, J = 2.6). 13C (CDCl3, 75 MHz) 
109.5, 118.7 (2C), 125.5 (2C), 127.2, 142.9, 144.5, 145.5. These 
values are consistent with those reported in the literature.10 
1-(4-Cyanophenyl)-1H-pyrazole (1d) was prepared from 4-80 
bromobenzonitrile using a described procedure10 (reaction time: 
144 h). Yield: 73%. White solid (mp = 86 °C). IR (ATR): 2971, 
1738, 1366, 1217, 748 cm-1. 1H (CDCl3, 300 MHz) 6.52 (dd, 1H, 
J = 1.8 and 2.6), 7.73 and 7.83 (AB, d, 4H, J = 9.0), 7.76 (d, 1H, 
J = 0.5 and 1.8), 7.99 (dd, 1H, J = 0.5 and 2.6). 13C (CDCl3, 75 85 
MHz) 109.2, 109.6, 118.5, 119.0 (2C), 126.9, 133.8 (2C), 142.5, 
143.0. These values are consistent with those reported in the 
literature.10 
1-[4-(Trifluoromethyl)phenyl]-1H-pyrazole (1e) was prepared 
from 1-bromo-4-(trifluoromethyl)benzene using a described 90 
procedure10 (reaction time: 94 h). Yield: 42%. White solid (mp = 
96 °C). IR (ATR): 1739, 1217, 1106, 1068, 822, 755 cm-1. 1H 
(CDCl3, 300 MHz) 6.52 (dd, 1H, J = 1.8 and 2.5), 7.72 and 7.84 
(AB, d, 4H, J = 8.5), 7.77 (dd, 1H, J = 0.5 and 1.8), 7.99 (dd, 1H, 
J = 0.5 and 2.5). 13C (CDCl3, 75 MHz) 108.6, 118.9 (2C), 124.0 95 
(q, JF = 272), 126.8 (q, 2C, JF = 4), 126.9, 128.3 (q, JF = 33), 
142.1, 142.6. 19F (CDCl3, 282 MHz) -62.3 (3F). These values are 
consistent with those reported in the literature.10 
1-(4-Fluorophenyl)-1H-pyrazole (1f) was prepared from 1-
bromo-4-fluorobenzene using a described procedure10 (reaction 100 
time: 24 h). Yield: 39%. White solid (mp < 50 °C). IR (ATR): 
3124, 1741, 1521, 1508, 1394, 1218, 832, 747 cm-1. 1H (CDCl3, 
300 MHz) 6.47 (dd, 1H, J = 1.8 and 2.3), 7.15 (dd, 2H, J = 9.2 
and JF = 8.2), 7.66 (dd, 2H, J = 9.2 and JF = 4.7), 7.72 (d, 1H, J = 
1.8), 7.86 (d, 1H, J = 2.3). 13C (CDCl3, 75 MHz) 107.7, 116.1 105 
(2C, d, JF = 23), 120.9 (2C, d, JF = 8), 126.9, 136.6, 141.1, 159.4 
(d, JF = 246). 19F (CDCl3, 282 MHz) -115.8. These values are 
consistent with those reported in the literature.27 
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1-(4-Methoxyphenyl)-1H-pyrazole (1g) was prepared from 4-
iodoanisole using a described procedure10 (reaction time: 42 h). 
Yield: 39%. Yellow solid (mp = 42 °C). IR (ATR): 1741, 1375, 
1230, 830 cm-1. 1H (CDCl3, 300 MHz) 3.83 (s, 3H), 6.43 (dd, 1H, 
J = 1.9 and 2.3), 6.96 and 7.58 (AB, d, 4H, J = 9.1), 7.69 (dd, 1H, 5 
J = 0.5 and 1.9), 7.82 (dd, 1H, J = 0.5 and 2.3). 13C (CDCl3, 75 
MHz) 55.7, 107.3, 114.6 (2C), 121.0 (2C), 126.9, 134.1, 140.7, 
158.3. These values are consistent with those reported in the 
literature.10 
1-(3-Methoxyphenyl)-1H-pyrazole (1h) was prepared from 3-10 
iodoanisole using a described procedure10 (reaction time: 91 h). 
Yield: 93%. Colourless liquid. IR (ATR): 3003, 2937, 2837, 
1606, 1594, 1392, 1225, 1044, 946, 843, 746 cm-1. 1H (CDCl3, 
300 MHz) 3.80 (s, 3H), 6.41 (dd, 1H, J = 1.8 and 2.5), 6.79 (ddd, 
1H, J = 1.0, 2.5 and 8.1), 7.19 (ddd, 1H, J = 1.0, 2.0 and 8.0), 15 
7.30 (m, 2H), 7.70 (dd, 1H, J = 0.5 and 1.8), 7.87 (dd, 1H, J = 0.5 
and 2.5). 13C (CDCl3, 75 MHz) 55.5, 105.0, 107.7, 111.1, 112.4, 
127.0, 130.2, 141.1, 141.3, 160.5. These values are consistent 
with those reported in the literature.28 
1,1'-(1,4-Phenylene)bis(1H-pyrazole) (1i) was prepared from 20 
1,4-diiodobenzene (5 equiv of pyrazole were employed) using a 
described procedure10 (reaction time: 260 h). Yield: 31%. White 
solid (mp = 180 °C). IR (ATR): 1742, 1529, 1392, 1330, 1105, 
936, 836, 757 cm-1. 1H (CDCl3, 300 MHz) 6.49 (dd, 2H, J = 1.9 
and 2.4), 7.74 (dd, 2H, J = 0.4 and 1.9), 7.78 (s, 4H), 7.94 (dd, 25 
2H, J = 0.4 and 2.4). 13C (CDCl3, 75 MHz) 108.0 (2C), 120.1 
(4C), 126.8 (2C), 138.4 (2C), 141.4 (2C). These values are 
consistent with those reported in the literature.10 
1,1'-(1,2-Phenylene)bis(1H-pyrazole) (1j) was prepared from 
1,2-diiodobenzene (3 equiv of pyrazole were employed) using a 30 
described procedure10 (reaction time: 24 h). Yield: 76%. White 
solid (mp = 70 °C). IR (ATR): 1738, 1366, 1217, 759 cm-1. 1H 
(CDCl3, 300 MHz) 6.29 (dd, 2H, 1.9 and 2.4), 7.00 (dd, 2H, 0.5 
and 2.4), 7.51 (m, 2H), 7.68 (m, 2H), 7.70 (dd, 2H, 0.5 and 1.9). 
13C (CDCl3, 75 MHz) 107.6 (2C), 127.1 (2C), 129.0 (2C), 130.6 35 
(2C), 134.7 (2C), 141.3 (2C). These values are consistent with 
those reported in the literature.29 
1-(Thiophen-2-yl)-1H-pyrazole (1k) was prepared from 2-
bromothiophene using a described procedure10 (reaction time: 24 
h). Yield: 52%. Colourless liquid. IR (ATR): 3109, 1737, 1556, 40 
1465, 1387, 1043, 918, 745 cm-1. 1H (CDCl3, 300 MHz) 6.41 (dd, 
1H, J = 1.6 and 2.4), 6.93 (dd, 1H, J = 4.6 and 4.6), 7.02 (d, 2H, J 
= 4.6), 7.66 (d, 1H, J = 0.5 and 1.6), 7.79 (dd, 1H, J = 0.5 and 
2.4). 13C (CDCl3, 75 MHz) 107.8, 114.0, 120.2, 126.1, 128.1, 
141.2, 143.8. These values are consistent with those reported in 45 
the literature.10 
1-(Thiophen-3-yl)-1H-pyrazole (1l) was prepared from 3-
bromothiophene using a described procedure10 (reaction time: 72 
h). Yield: 64%. Colourless liquid. IR (ATR): 3111, 1740, 1557, 
1397, 1035, 854, 767, 744 cm-1. 1H (CDCl3, 300 MHz) 6.41 (dd, 50 
1H, J = 1.9 and 2.4), 7.34-7.40 (m, 3H), 7.67 (dd, 1H, J = 1.9 and 
0.6), 7.80 (dd, 1H, J = 0.6 and 2.4). 13C (CDCl3, 75 MHz) 107.0, 
110.5, 120.2, 126.5, 127.4, 139.8, 140.6. These values are 
consistent with those reported in the literature.10 
1-(2-Chloropyridin-4-yl)-1H-pyrazole (1m) was prepared from 55 
4-bromo-2-chloropyridine using a described procedure10 (reaction 
time: 24 h). Yield: 60%. White solid (mp = 112 °C). IR (ATR): 
2971, 1740, 1595, 1570, 1381, 1217, 1084, 836, 750 cm-1. 1H 
(CDCl3, 300 MHz) 6.55 (dd, 1H, J = 1.8 and 2.6), 7.56 (dd, 1H, J 
= 1.8 and 5.6), 7.71 (d, 1H, J = 1.8), 7.79 (d, 1H, J = 1.8), 8.0 (d, 60 
1H, J = 2.6), 8.42 (d, 1H, J = 5.6). 13C (CDCl3, 75 MHz) 109.8, 
111.5, 112.9, 126.9, 143.2, 148.0, 151.0, 153.1. HRMS (ESI): 
calcd for C8H7ClN3 [M+H]+ 180.0328, found 180.0321. 
1-(Pyridin-4-yl)-1H-pyrazole (1n) was prepared from 4-
bromopyridine hydrochloride (1 additional equivalent of Cs2CO3 65 
was used) using a described procedure10 (reaction time: 24 h). 
Yield: 61%. White solid (mp = 84 °C). IR (ATR): 2971, 1738, 
1595, 1366, 1217, 1035, 817, 757 cm-1. 1H (CDCl3, 300 MHz) 
6.48 (dd, 1H, J = 1.7 and 2.6), 7.59 (br d, 2H, J = 5.5), 7.73 (dd, 
1H, J = 1.7 and 0.4), 8.00 (dd, 1H, J = 2.6 and 0.4), 8.61 (br d, 70 
2H, J = 5.5). 13C (CDCl3, 75 MHz) 109.1, 112.6 (2C), 126.6, 
142.5, 145.9, 151.2 (2C). HRMS (ESI): calcd for C8H8N3 
[M+H]+ 146.0718, found 146.0719. 
1-(Pyridin-3-yl)-1H-pyrazole (1o) was prepared from 3-
bromopyridine using a described procedure10 (reaction time: 26 75 
h). Yield: 67%. Yellow solid (mp < 50 °C). IR (ATR): 3115, 1739, 
1586, 1521, 1391, 1045, 934, 748 cm-1. 1H (CDCl3, 300 MHz) 
6.53 (dd, 1H, J = 1.8 and 2.5), 7.44 (dd, 1H, J = 4.7 and 8.3), 7.78 
(dd, 1H, J = 0.4 and 1.8), 7.97 (dd, 1H, J = 0.4 and 2.5), 8.07 
(ddd, 1H, J = 1.3, 2.6 and 8.3), 8.55 (dd, 1H, J = 1.3 and 4.7), 80 
9.00 (d, 1H, J = 2.6). 13C (CDCl3, 75 MHz) 108.5, 124.1, 126.6, 
126.9, 136.6, 140.6, 142.1, 147.6. These values are consistent 
with those reported in the literature.10 
1-(Pyridin-2-yl)-1H-pyrazole (1p) was prepared from 2-
bromopyridine using a described procedure10 (reaction time: 24 85 
h). Yield: 76%. White solid (mp < 50 °C). IR (ATR): 3127, 3093, 
2971, 1738, 1590, 1453, 1388, 1198, 936, 759 cm-1. 1H (CDCl3, 
300 MHz) 6.46 (dd, 1H, J = 1.7 and 2.6), 7.17 (br dd, 1H, J = 4.9 
and 7.3), 7.73 (dd, 1H, J = 0.7 and 1.7), 7.80 (br ddd, 1H, J = 1.8, 
7.3 and 8.3), 7.98 (br d, 1H, J = 8.3), 8.40 (br dd, 1H, J = 1.8 and 90 
4.9), 8.57 (dd, 1H, J = 0.7 and 2.6). 13C (CDCl3, 75 MHz) 107.9, 
112.5, 121.5, 127.1, 138.9, 142.1, 148.1, 151.7. These values are 
consistent with those reported in the literature.30 
1-(Pyrimidin-2-yl)-1H-pyrazole (1q) was prepared from 2-
chloropyrimidine using a described procedure10 (reaction time: 72 95 
h). Yield: 73%. White solid (mp = 80 °C). IR (ATR): 2971, 1738, 
1456, 1434, 1366, 1229, 1217, 931, 765 cm-1. 1H (CDCl3, 300 
MHz) 6.50 (dd, 1H, J = 1.6 and 2.7), 7.20 (t, 1H, J = 4.8), 7.82 
(dd, 1H, J = 0.6 and 0.9), 8.59 (dd, 1H, J = 0.6 and 2.7), 8.74 (d, 
2H, J = 4.8). 13C (CDCl3, 75 MHz) 108.6, 118.6, 129.0, 143.5, 100 
155.8, 158.7 (2C). These values are consistent with those reported 
in the literature.31 
General procedure for the deproto-zincation followed by 
iodination. To a stirred, cooled (0°C) solution of 2,2,6,6-
tetramethylpiperidine (0.25 mL, 1.5 mmol) in THF (5 mL) was 105 
added BuLi (about 1.6 M hexanes solution, 1.5 mmol). After 15 
min at 0°C, ZnCl2·TMEDA (0.125 g, 0.5 mmol) was added, and 
the mixture was stirred for 15 min at this temperature before 
introduction of the substrate (1.0 mmol). After 2 h at room 
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temperature, a solution of I2 (0.37 g, 1.5 mmol) in THF (5 mL) 
was added. The mixture was stirred overnight before addition of 
an aqueous saturated solution of Na2S2O3 (10 mL) and extraction 
with Et2O (3 x 20 mL). The combined organic layers were 
washed with brine (20 mL), dried over Na2SO4, filtered, and 5 
concentrated under reduced pressure before purification by flash 
chromatography on silica gel. 
1-[4-(tert-Butyl)phenyl]-5-iodo-1H-pyrazole (2a) was prepared 
from 1a following the general procedure and was obtained as a 
yellow liquid (54% yield; 4% using 3.0 mmol of 2,2,6,6-10 
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA). IR (ATR): 2962, 2905, 2868, 1511, 1385, 1079, 
957, 917, 836, 773 cm-1. 1H (CDCl3, 300 MHz) 1.36 (s, 9H), 6.61 
(d, 1H, J = 1.9), 7.34 and 7.49 (AB, d, 4H, J = 9.0), 7.67 (d, 1H, J 
= 1.9). 13C (CDCl3, 75 MHz) 31.4 (3C), 34.9, 80.8, 117.3, 125.7 15 
(2C), 125.8 (2C), 137.7, 142.6, 151.8. HRMS (ESI): calcd for 
C13H16IN2 [M+H]+ 327.0358, found 327.0354. 
1-[4-(tert-Butyl)-2-iodophenyl)-5-iodo-1H-pyrazole (3a) was 
prepared from 1a following the general procedure and was 
obtained as a yellow liquid (28% yield; 66% using 3.0 mmol of 20 
2,2,6,6-tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA). IR (ATR): 2962, 2925, 2870, 1600, 1517, 1392, 
1364, 1202, 1109, 831 cm-1. 1H (CDCl3, 300 MHz) 1.35 (s, 9H), 
6.62 (d, 1H, J = 1.9), 7.26 (d, 1H, J = 8.2), 7.47 (dd, 1H, J = 2.1 
and 8.2), 7.69 (d, 1H, J = 1.9), 7.92 (d, 1H, J = 2.1). 13C (CDCl3, 25 
75 MHz) 31.3 (3C), 35.0, 83.6, 98.2, 116.3, 126.2, 129.1, 136.8, 
140.5, 142.8, 155.1. HRMS (ESI): calcd for C13H15I2N2 [M+H]+ 
452.9325, found 452.9328. 
1-[4-(Dimethylamino)phenyl]-5-iodo-1H-pyrazole (2b) was 
prepared from 1b following the general procedure and was 30 
obtained as a white solid (54% yield; mp = 140 °C). IR (ATR): 
2925, 1728, 1609, 1535, 1370, 1187, 959, 808, 784 cm-1. 1H 
(CDCl3, 300 MHz) 3.02 (s, 6H), 6.57 (d, 1H, J = 1.9), 6.74 and 
7.31 (AB, d, 4H, J = 9.1), 7.64 (d, 1H, J = 1.9). 13C (CDCl3, 75 
MHz) 40.6 (2C), 82.2, 111.7 (2C), 116.5, 127.4 (2C), 129.5, 35 
142.2, 150.5. HRMS (ESI): calcd for C11H13IN3 [M+H]+ 
314.0154, found 314.0152. 
1-[4-(Dimethylamino)-2-iodophenyl)-5-iodo-1H-pyrazole (3b) 
was prepared from 1b following the general procedure and was 
obtained as a white solid (28% yield; 67% using 3.0 mmol of 40 
2,2,6,6-tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 186 °C). IR (ATR): 2923, 2853, 1732, 
1597, 1515, 1446, 1357, 1061, 1010, 954 cm-1. 1H (CDCl3, 300 
MHz) 3.01 (s, 6H), 6.59 (d, 1H, J = 1.9), 6.69 (dd, 1H, J = 2.8 
and 8.8), 7.13 (d, 1H, J = 8.8), 7.15 (d, 1H, J = 2.8), 7.67 (d, 1H, 45 
J = 1.9). 13C (CDCl3, 75 MHz) 40.4 (2C), 85.1, 99.3, 111.5, 115.8, 
121.5, 129.3, 131.4, 142.4, 151.5. HRMS (ESI): calcd for 
C11H12I2N3 [M+H]+ 439.9121, found 439.9124. 
1-[4-(Dimethylamino)phenyl]-5-phenyl-1H-pyrazole (4b). A 
solution of 2b (0.16 g, 0.5 mmol), phenylboronic acid (0.30 g, 2.5 50 
mmol), and CsF (0.15 g, 1.0 mmol) in dioxane (5 mL) was 
degassed with Ar for 30 min before addition of Pd(dba)2 (14 mg, 
25 mol), and PPh3 (26 mg, 0.10 mmol). The resulting mixture 
was heated at 105 °C for 12 h, before cooling and dilution with 
Et2O (30 mL), washing with H2O, and extraction with CH2Cl2 (3 55 
x 20 mL). After drying over Na2SO4, the solvent was evaporated 
under reduced pressure, and the coupled product 4b was isolated 
by purification by flash chromatography on silica gel as a white 
solid (73% yield; mp = 140 °C). IR (ATR): 2891, 2805, 1624, 
1524, 1361, 1068, 924, 803 cm-1. 1H (CDCl3, 300 MHz) 2.96 (s, 60 
6H), 6.48 (d, 1H, J = 1.4), 6.65 (d, 2H, J = 8.8), 7.15 (d, 2H, J = 
8.8), 7.25-7.29 (m, 5H), 7.68 (d, 1H, J = 1.4). 13C (CDCl3, 75 
MHz) 40.8 (2C), 107.1, 112.4 (2C), 126.3 (2C), 128.0, 128.5 
(2C), 128.8 (2C), 131.0, 132.4, 139.7, 142.8, 149.6. HRMS (ESI): 
calcd for C17H18N3 [M+H]+ 264.1501, found 264.1499. 65 
1-(4-Cyano-2-iodophenyl)-5-iodo-1H-pyrazole (3d) was 
prepared from 1d following the general procedure and was 
obtained as a white solid (65% yield; mp = 112 °C). IR (ATR): 
2924, 2852, 2230, 1608, 1525, 1493, 1389, 1026, 957, 837 cm-1. 
1H (CDCl3, 300 MHz) 6.67 (d, 1H, J = 1.7), 7.45 (d, 1H, J = 8.1), 70 
7.73 (d, 1H, J = 1.8), 7.79 (dd, 1H, J = 1.8 and 8.1), 8.25 (d, 1H, 
J = 1.7). 13C (CDCl3, 75 MHz) 82.8, 98.8, 115.2, 116.2, 117.1, 
130.3, 132.6, 142.9, 143.5, 146.7. HRMS (ESI): calcd for 
C10H6I2N3 [M+H]+ 421.8651, found 421.8655. 
5-Iodo-1-[2-iodo-4-(trifluoromethyl)phenyl]-1H-pyrazole (3e) 75 
was prepared from 1e following the general procedure and was 
obtained as a yellow liquid (84% yield). IR (ATR): 1604, 1501, 
1397, 1383, 1317, 1169, 1126, 1070, 957, 709 cm-1. 1H (CDCl3, 
300 MHz) 6.65 (d, 1H, J = 1.8), 7.46 (d, 1H, J = 8.2), 7.72 (d, 
1H, J = 1.7), 7.76 (dd, 1H, J = 1.7 and 8.2), 8.21 (d, 1H, J = 1.8). 80 
13C (CDCl3, 75 MHz) 83.0, 98.6, 116.7, 122.3 (q, JF = 273), 
125.9 (q, JF = 4), 130.1, 132.9 (q, JF = 33), 136.6 (q, JF = 4), 
143.1, 146.0. 19F (CDCl3, 282 MHz) -62.6 (3F). HRMS (ESI): 
calcd for C10H6F3I2N2 [M+H]+ 464.8573, found 464.8572. 
1-(4-Fluoro-2-iodophenyl)-5-iodo-1H-pyrazole (3f) was 85 
prepared from 1f following the general procedure and was 
obtained as a yellow solid (31% yield; 57% using 3.0 mmol of 
2,2,6,6-tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 78 °C). IR (ATR): 3097, 1589, 1492, 1393, 
1202, 1023, 958, 862 cm-1. 1H (CDCl3, 300 MHz) 6.63 (d, 1H, J 90 
= 1.9), 7.19 (ddd, 1H, J = 2.7, 8.7 and JF = 7.7), 7.32 (dd, 1H, J = 
8.7 and JF = 5.3), 7.67 (dd, 1H, J = 2.7 and JF = 7.7), 7.70 (d, 1H, 
J = 1.9). 13C (CDCl3, 75 MHz) 83.7, 98.6 (d, JF = 9), 116.0 (d, JF 
= 23), 116.5, 126.5 (d, JF = 25), 130.6 (d, JF = 9), 139.4, (d, JF = 
4), 143.0, 162.2 (d, JF = 255). 19F (CDCl3, 282 MHz) -108.9. 95 
HRMS (ESI): calcd for C9H6FI2N2 [M+H]+ 414.8605, found 
414.8605. 
1-(4-Fluoro-3-iodophenyl)-5-iodo-1H-pyrazole (3'f) was 
prepared from 1f following the general procedure and was 
obtained as a brown solid (22% yield using 3.0 mmol of 2,2,6,6-100 
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 61 °C). IR (ATR): 3097, 2924, 1591, 1491, 
1389, 1038, 965, 819 cm-1. 1H (CDCl3, 300 MHz) 6.62 (d, 1H, J 
= 1.8), 7.16 (dd, 1H, J = 8.9 and JF = 7.3), 7.51 (ddd, 1H, J = 2.7, 
8.9 and JF = 4.5), 7.67 (d, 1H, J = 1.8), 7.93 (dd, 1H, J = 2.7 and 105 
JF = 5.4). 13C (CDCl3, 75 MHz) 81.0 (d, JF = 28), 81.1, 115.5 (d, 
JF = 26), 118.0, 128.1 (d, JF = 8), 137.3 (d, JF = 3), 143.2, 143.3, 
161.7 (d, JF = 248). 19F (CDCl3, 282 MHz) -93.4. HRMS (ESI): 
calcd for C9H6FI2N2 [M+H]+ 414.8605, found 414.8627. 
5-Iodo-1-(2-iodo-4-methoxyphenyl)-1H-pyrazole (3g) was 110 
prepared from 1g following the general procedure and was 
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obtained as a white solid (60% yield; mp = 98 °C). IR (ATR): 
3005, 2925, 2852, 1592, 1567, 1496, 1396, 1384, 1291, 1231, 
1221, 1027, 1017, 957, 917 cm-1. 1H (CDCl3, 300 MHz) 3.86 (s, 
3H), 6.61 (d, 1H, J = 1.9), 6.98 (dd, 1H, J = 2.8 and 8.7), 7.25 (d, 
1H, J = 8.7), 7.45 (d, 1H, J = 2.8), 7.71 (d, 1H, J = 1.9). 13C 5 
(CDCl3, 75 MHz) 56.0, 84.4, 98.8, 114.6, 116.2, 124.4, 130.0, 
136.1, 142.8, 160.6. HRMS (ESI): calcd for C10H9I2N2O [M+H]+ 
426.8804, found 426.8811. 
5-Iodo-1-(3-methoxyphenyl)-1H-pyrazole (2h) was prepared 
from 1h following the general procedure and was obtained as a 10 
yellow liquid (12% yield; 70% using 1.0 mmol of 2,2,6,6-
tetramethylpiperidine, 1.0 mmol of BuLi and 0.33 mmol of 
ZnCl2·TMEDA). IR (ATR): 2961, 2835, 1606, 1593, 1497, 1384, 
1219, 1036, 971, 847 cm-1. 1H (CDCl3, 300 MHz) 3.85 (s, 3H), 
6.62 (d, 1H, J = 1.9), 6.98 (ddd, 1H, J = 0.9, 2.4 and 8.2), 7.06 15 
(dd, 1H, J = 2.0 and 2.4), 7.11 (ddd, 1H, J = 0.9, 2.0 and 7.9), 
7.38 (dd, 1H, J = 7.9 and 8.2), 7.68 (d, 1H, J = 1.9). 13C (CDCl3, 
75 MHz) 55.7, 80.8, 111.8, 115.0, 117.6, 118.6, 129.6, 141.2, 
142.7, 159.9. HRMS (ESI): calcd for C10H10IN2O [M+H]+ 
300.9838, found 300.9836. 20 
5-Iodo-1-(2-iodo-3-methoxyphenyl)-1H-pyrazole (3h) was 
prepared from 1h following the general procedure and was 
obtained as a yellow solid (61% yield; 7% using 1.0 mmol of 
2,2,6,6-tetramethylpiperidine, 1.0 mmol of BuLi and 0.33 mmol 
of ZnCl2·TMEDA; mp = 132 °C). IR (ATR): 3005, 2934, 2836, 25 
1733, 1575, 1472, 1400, 1218, 1130, 971 cm-1. 1H (CDCl3, 300 
MHz) 3.96 (s, 3H), 6.63 (d, 1H, J = 1.9), 6.93 (dd, 1H, J = 1.2 
and 8.4), 6.99 (dd, 1H, J = 1.2 and 7.8), 7.44 (dd, 1H, J = 7.8 and 
8.4), 7.70 (dd, 1H, J = 1.9). 13C (CDCl3, 75 MHz) 57.0, 83.4, 
91.3, 111.9, 116.5, 122.1, 129.7, 139.8, 142.7, 159.4. HRMS 30 
(ESI): calcd for C10H9I2N2O [M+H]+ 426.8804, found 426.8810. 
1,1'-[1,4-(2-Iodophenylene)bis-(1H-5-iodopyrazole)] (5i) was 
prepared from 1i following the general procedure and was 
obtained as a white solid (61% yield using 3.0 mmol of 2,2,6,6-
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 35 
ZnCl2·TMEDA; mp = 174 °C). IR (ATR): 3129, 2924, 2854, 
1724, 1592, 1501, 1393, 1372, 954, 917 cm-1. 1H (CDCl3, 300 
MHz) 6.64 (d, 1H, J = 1.8), 6.65 (d, 1H, J = 1.8), 7.44 (d, 1H, J = 
8.4), 7.70 (dd, 1H, J = 2.3 and 8.4), 7.71 (d, 1H, J = 1.8), 7.72 (d, 
1H, J = 1.8), 8.17 (d, 1H, J = 2.3). 13C (CDCl3, 75 MHz) 80.6, 40 
83.6, 98.1, 116.7, 118.7, 126.3, 129.6, 136.7, 141.4, 142.8, 143.1, 
143.6. HRMS (ESI): calcd for C12H8I3N4 [M+H]+ 588.7883, 
found 588.7897. 
1,1'-[1,2-(3-Iodophenylene)bis(1H-5-iodopyrazole) (5j) was 
prepared from 1j following the general procedure and was 45 
obtained as a white solid (37% yield using 3.0 mmol of 2,2,6,6-
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 214 °C). IR (ATR): 2924, 2853, 1731, 
1485, 1455, 1405, 1382, 956, 917 cm-1. 1H (CDCl3, 300 MHz) 
6.44 (d, 1H, J = 1.9), 6.45 (d, 1H, J = 1.9), 7.37 (dd, 1H, J = 7.9 50 
and 8.0), 7.43 (d, 1H, J = 1.9), 7.52 (d, 1H, J = 1.9), 7.53 (dd, 1H, 
J = 1.4 and 7.9), 8.11 (dd, 1H, J = 1.4 and 8.0). 13C (CDCl3, 75 
MHz) 83.4, 84.4, 100.8, 116.4, 116.8, 129.7, 131.4, 139.3, 140.6, 
140.7, 142.8, 143.0. HRMS (ESI): calcd for C12H8I3N4 [M+H]+ 
588.7883, found 588.7904. 55 
1,1'-(1,2-Phenylene)bis(1H-5-iodopyrazole) (6j) was prepared 
from 1j following the general procedure and was obtained as a 
white solid (37% yield using 3.0 mmol of 2,2,6,6-
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 182 °C). IR (ATR): 3129, 2924, 2854, 60 
1515, 1405, 1384, 958, 917 cm-1. 1H (CDCl3, 300 MHz) 6.45 (d, 
2H, J = 1.9), 7.47 (d, 2H, J = 1.9), 7.59 (m, 4H). 13C (CDCl3, 75 
MHz) 82.9 (2C), 116.7 (2C), 129.7 (2C), 129.8 (2C), 137.0 (2C), 
142.8 (2C). HRMS (ESI): calcd for C12H9I2N4 [M+H]+ 462.8917, 
found 462.8939. 65 
5-Iodo-1-(5-iodothiophen-2-yl)-1H-pyrazole (8'k) was prepared 
from 1k following the general procedure and was obtained as a 
white solid (55% yield; mp = 64 °C). IR (ATR): 3107, 2923, 
1552, 1403, 1364, 1205, 945, 906 cm-1. 1H (CDCl3, 300 MHz) 
6.60 (d, 1H, J = 1.8), 6.94 (d, 1H, J = 4.0), 7.20 (d, 1H, J = 4.0), 70 
7.66 (d, 1H, J = 1.8). 13C (CDCl3, 75 MHz) 72.6, 83.1, 118.1, 
124.7, 135.3, 143.6, 145.7. HRMS (ESI): calcd for C7H5I2N2S 
[M+H]+ 402.8263, found 402.8272. 
5-Iodo-1-(3-iodothiophen-2-yl)-1H-pyrazole (8k) was 
identified in an inseparable mixture with the starting material 75 
(11% estimated yield). 1H (CDCl3, 300 MHz) 6.64 (d, 1H, J = 
1.9), 7.10 (d, 1H, J = 5.7), 7.40 (d, 1H, J = 5.7), 7.73 (d, 1H, J = 
1.9). 
1-(2-Iodothiophen-3-yl)-1H-pyrazole (7'l) was prepared from 1l 
following the general procedure and was obtained as a yellow 80 
liquid (30% yield; 62% using 1.0 mmol of 2,2,6,6-
tetramethylpiperidine, 1.0 mmol of BuLi and 0.33 mmol of 
ZnCl2·TMEDA). IR (ATR): 3108, 2923, 2853, 1547, 1455, 1392, 
1065, 1042, 853 cm-1. 1H (CDCl3, 300 MHz) 6.46 (dd, 1H, J = 
1.5 and 2.0), 7.10 (d, 1H, J = 5.7), 7.53 (d, 1H, J = 5.7), 7.73 (d, 85 
1H, J = 1.5), 7.96 (d, 1H, J = 2.0). 13C (CDCl3, 75 MHz) 66.5, 
106.7, 125.3, 130.0, 131.6, 140.9, 143.4. HRMS (ESI): calcd for 
C7H6IN2S [M+H]+ 276.9296, found 276.9301. 
5-Iodo-1-(2-iodothiophen-3-yl)-1H-pyrazole (8l) was prepared 
from 1l following the general procedure and was obtained as a 90 
white solid (41% yield; 31% using 1.0 mmol of 2,2,6,6-
tetramethylpiperidine, 1.0 mmol of BuLi and 0.33 mmol of 
ZnCl2·TMEDA; mp = 104 °C). IR (ATR): 3103, 2922, 2853, 
1723, 1534, 1390, 987, 970, 917, 857 cm-1. 1H (CDCl3, 300 
MHz) 6.63 (d, 1H, J = 1.8), 6.96 (d, 1H, J = 5.6), 7.57 (d, 1H, J = 95 
5.6), 7.71 (d, 1H, J = 1.8). 13C (CDCl3, 75 MHz) 77.9, 83.6, 
116.5, 126.8, 131.1, 143.1, 143.2. HRMS (ESI): calcd for 
C7H5I2N2S [M+H]+ 402.8263, found 402.8273. 
1-(2-Chloropyridin-4-yl)-5-iodo-1H-pyrazole (7m) was formed 
from 1m following the general procedure (8% estimated yield 100 
using 1.0 mmol of 2,2,6,6-tetramethylpiperidine, 1.0 mmol of 
BuLi and 0.33 mmol of ZnCl2·TMEDA) and was identified in an 
inseparable mixture with the starting material. 1H (CDCl3, 300 
MHz) 6.71 (d, 1H, J = 1.8), 7.63 (dd, 1H, J = 1.9 and 5.5), 7.73 
(dd, 1H, J = 0.5 and 1.9), 7.74 (d, 1H, J = 1.8), 8.50 (dd, 1H, J = 105 
0.5 and 5.5). 
1-(2-Chloro-3-iodopyridin-4-yl)-5-iodo-1H-pyrazole (8m) was 
formed from 1m following the general procedure (18% estimated 
yield; 11% using 1.0 mmol of 2,2,6,6-tetramethylpiperidine, 1.0 
mmol of BuLi and 0.33 mmol of ZnCl2·TMEDA; 5% using 3.0 110 
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mmol of 2,2,6,6-tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 
mmol of ZnCl2·TMEDA) and was identified in an inseparable 
mixture with 8'm. 1H (CDCl3, 300 MHz) 6.69 (d, 1H, J = 1.9), 
7.20 (d, 1H, J = 5.0), 7.75 (d, 1H, J = 1.9), 8.49 (d, 1H, J = 5.0). 
13C (CDCl3, 75 MHz) 86.2, 100.5, 117.5, 123.0, 141.8, 149.6, 5 
157.2, 159.1. 
1-(2-Chloro-5-iodopyridin-4-yl)-5-iodo-1H-pyrazole (8'm) was 
prepared from 1m following the general procedure and was 
obtained as a white solid (34% yield; 26% using 1.0 mmol of 
2,2,6,6-tetramethylpiperidine, 1.0 mmol of BuLi and 0.33 mmol 10 
of ZnCl2·TMEDA; 9% using 3.0 mmol of 2,2,6,6-
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 118 °C). IR (ATR): 3127, 3069, 2922, 
2854, 1560, 1532, 1407, 1388, 1107, 1015, 967, 917, 872 cm-1. 
1H (CDCl3, 300 MHz) 6.67 (d, 1H, J = 1.9), 7.38 (s, 1H), 7.73 (d, 15 
1H, J = 1.9), 8.86 (s, 1H). 13C (CDCl3, 75 MHz) 82.0, 94.5, 
117.7, 125.6, 144.1, 151.9, 152.3, 158.2. HRMS (ESI): calcd for 
C8H5ClI2N3 [M+H]+ 431.8261, found 431.8260. 
1-(2-Chloro-3,5-diiodopyridin-4-yl)-5-iodo-1H-pyrazole (9m) 
was prepared from 1m following the general procedure and was 20 
obtained as a white solid (12% yield; 48% using 3.0 mmol of 
2,2,6,6-tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 184 °C). IR (ATR): 2923, 2854, 1724, 
1562, 1531, 1451, 1399, 1194, 1109, 1029, 968, 917 cm-1. 1H 
(CDCl3, 300 MHz) 6.72 (d, 1H, J = 1.9), 7.79 (d, 1H, J = 1.9), 25 
8.75 (s, 1H). 13C (CDCl3, 75 MHz) 81.3, 95.1, 101.9, 117.7, 
144.4, 154.7, 156.4, 156.5. HRMS (ESI): calcd for C8H4ClI3N3 
[M+H]+ 557.7228, found 557.7241. 
5-Iodo-1-(pyridin-4-yl)-1H-pyrazole (7n) was prepared from 1n 
following the general procedure and was obtained as a brown 30 
solid (8% yield; mp = 122 °C). IR (ATR): 3120, 3095, 3051, 
2923, 2853, 1587, 1575, 1498, 1403, 1403, 1373, 1211, 1074, 
1022, 962, 915, 825 cm-1. 1H (CDCl3, 300 MHz) 6.70 (d, 1H, J = 
1.8), 7.64 (dd, 2H, J = 1.6 and 4.6), 7.74 (d, 1H, J = 1.8), 8.74 
(dd, 2H, J = 1.6 and 4.6). 13C (CDCl3, 75 MHz) 79.0, 119.5 (2C), 35 
119.7, 144.1, 146.9, 150.9 (2C). HRMS (ESI): calcd for C8H7IN3 
[M+H]+ 271.9685, found 271.9690. 
5-Iodo-1-(3-iodopyridin-4-yl)-1H-pyrazole (8n) was prepared 
from 1n following the general procedure and was obtained as a 
brown solid (60% yield; mp = 115 °C). IR (ATR): 3127, 3041, 40 
1567, 1487, 1395, 1376, 1016, 961, 917, 833 cm-1. 1H (CDCl3, 
300 MHz) 6.62 (d, 1H, J = 1.9), 7.29 (d, 1H, J = 5.0), 7.68 (d, 
1H, J = 1.9), 8.64 (d, 1H, J = 5.0), 9.07 (s, 1H). 13C (CDCl3, 75 
MHz) 82.2, 96.8, 117.2, 124.5, 143.5, 149.8, 150.1, 158.7. HRMS 
(ESI): calcd for C8H5I2N3 [M+H]+ 397.8651, found 397.8661. 45 
5-Iodo-1-(2-iodopyridin-3-yl)-1H-pyrazole (8o) was prepared 
from 1o following the general procedure and was obtained as a 
white solid (28% yield; mp = 138 °C). 1H (CDCl3, 300 MHz) 
6.68 (d, 1H, J = 1.8), 7.43 (dd, 1H, J = 4.7 and 7.8), 7.61 (dd, 1H, 
J = 1.9 and 7.8), 7.74 (d, 1H, J = 1.8), 8.51 (dd, 1H, J = 1.9 and 50 
4.7). 13C (CDCl3, 75 MHz) 83.8, 117.2, 122.2, 123.1, 137.0, 
141.1, 143.6, 151.4. HRMS (ESI): calcd for C8H5I2N3 396.8573, 
found 396.8547. 
5-Iodo-1-(4-iodopyridin-3-yl)-1H-pyrazole (8'o) was prepared 
from 1o following the general procedure and was obtained as a 55 
white solid (30% yield; mp = 175 °C). 1H (CDCl3, 300 MHz) 
6.68 (d, 1H, J = 1.9), 7.75 (d, 1H, J = 1.9), 7.95 (d, 1H, J = 5.2), 
8.32 (d, 1H, J = 5.2), 8.50 (s, 1H). 13C (CDCl3, 75 MHz) 83.7, 
110.0, 117.1, 134.5, 140.7, 143.7, 149.5, 150.7. HRMS (ESI): 
calcd for C8H5I2N3 396.8573, found 396.8564. 60 
5-Iodo-1-(pyridin-2-yl)-1H-pyrazole (7p) was prepared from 1p 
following the general procedure and was obtained as a colourless 
liquid (45% yield). IR (ATR): 3059, 3016, 1588, 1577, 1468, 
1442, 1404, 1373, 960, 916, 778 cm-1. 1H (CDCl3, 300 MHz) 
6.69 (d, 1H, J = 1.6), 7.33 (ddd, 1H, J = 1.1, 4.9 and 7.3), 7.71 (d, 65 
1H, J = 1.6), 7.77 (br d, 1H, J = 8.1), 7.86 (ddd, 1H, J = 1.9, 7.3 
and 8.1), 8.56 (br d, 1H, J = 4.9). 13C (CDCl3, 75 MHz) 77.4, 
118.3, 119.5, 123.1, 138.6, 143.5, 147.9, 152.4. HRMS (ESI): 
calcd for C8H6IN3Na [M+Na]+ 293.9504, found 293.9509. 
5-Iodo-1-(3-iodopyridin-2-yl)-1H-pyrazole (8p) was prepared 70 
from 1p following the general procedure and was obtained as a 
yellow solid (14% yield; 49% using 3.0 mmol of 2,2,6,6-
tetramethylpiperidine, 3.0 mmol of BuLi and 1.0 mmol of 
ZnCl2·TMEDA; mp = 238 °C). IR (ATR): 3126, 1590, 1565, 
1470, 1445, 1403, 1377, 962, 785 cm-1. 1H (CDCl3, 300 MHz) 75 
6.66 (d, 1H, J = 1.8), 7.20 (dd, 1H, J = 4.7 and 7.9), 7.73 (d, 1H, 
J = 1.8), 8.33 (dd, 1H, J = 1.6 and 7.9), 8.61 (dd, 1H, J = 1.6 and 
4.7). 13C (CDCl3, 75 MHz) 81.2, 93.7, 116.8, 126.2, 143.1, 148.7, 
149.0, 150.6. HRMS (ESI): calcd for C8H5I2N3Na [M+Na]+ 
419.8471, found 419.8469. 80 
5-Iodo-1-(pyrimidin-2-yl)-1H-pyrazole (7q) was prepared from 
1q following the general procedure and was obtained as a white 
solid (60% yield; mp = 100 °C). IR (ATR): 3127, 1569, 1427, 
1402, 964, 915, 813, 740 cm-1. 1H (CDCl3, 300 MHz) 6.75 (d, 
1H, J = 1.6), 7.33 (t, 1H, J = 4.8), 7.80 (d, 1H, J = 1.6), 8.84 (d, 85 
2H, J = 4.8). 13C (CDCl3, 75 MHz) 77.7, 119.8, 121.0, 144.7, 
156.9, 158.6 (2C). HRMS (ESI): calcd for C7H6IN4 [M+H]+ 
272.9637, found 272.9631. 
Crystallography 
Single crystals suitable for X-ray diffraction were grown after 90 
slow evaporation of solutions of 1j, 1n, 1o, 2b, 3b, 4b, 6j, 8l, 9m, 
7n, 8n and 8o in dichloromethane at room temperature. 
The samples were studied with graphite monochromatized Mo-
K radiation ( = 0.71073 Å). Except for 8o (T = 100(2) K), X-
ray diffraction data were collected at T = 150(2) K using APEXII 95 
Bruker-AXS diffractometer. The structure was solved by direct 
methods using the SIR97 program,32 and then refined with full-
matrix least-square methods based on F2 (SHELX-97)33 with the 
aid of the WINGX program.34 All non-hydrogen atoms were 
refined with anisotropic thermal parameters. H atoms were finally 100 
included in their calculated positions. Except N-linked hydrogen 
that was introduced in the structural model through Fourier 
difference maps analysis, H atoms were finally included in their 
calculated positions. Molecular diagrams were generated by 
ORTEP-3 (version 2.02).35 105 
Crystal data for 1j. C12H10N4, Mr = 210.24, monoclinic, P21/c, a 
= 7.745(4), b = 12.472(6), c = 10.787(5) Å,  = 92.060(14)°, V = 
1041.3(9) Å3, Z = 4, calcd = 1.341 g cm−3,  = 0.086 mm−1. A 
final refinement on F2 with 2360 unique intensities and 146 
 12 
parameters converged at R(F2) = 0.1467 (R(F) = 0.0685) for 
1062 observed reflections with I > 2(I). 
Crystal data for 1n. C8H7N3, Mr = 145.17, monoclinic, C2/c, a = 
18.2414(9), b = 5.4302(2), c = 14.7271(7) Å,  = 105.429(2)°, V 
= 1406.21(11) Å3, Z = 8, calcd = 1.371 g cm−3,  = 0.088 mm−1. 5 
A final refinement on F2 with 1599 unique intensities and 100 
parameters converged at R(F2) = 0.1059 (R(F) = 0.0397) for 
1382 observed reflections with I > 2(I). 
Crystal data for 1o. C8H7N3, Mr = 145.17, monoclinic, P21/a, a 
= 11.299(3), b = 4.2309(9), c = 14.743(3) Å,  = 90.229(8)°, V = 10 
704.8(3) Å3, Z = 4, calcd = 1.368 g cm−3,  = 0.088 mm−1. A final 
refinement on F2 with 1606 unique intensities and 100 parameters 
converged at R(F2) = 0.1401 (R(F) = 0.0565) for 1174 observed 
reflections with I > 2(I). 
Crystal data for 2b. C11H12IN3, Mr = 313.14, monoclinic, P21/n, 15 
a = 7.3777(3), b = 19.1576(9), c = 8.7098(4) Å,  = 111.017(2)°, 
V = 1149.14(9) Å3, Z = 4, calcd = 1.81 g cm−3,  = 2.758 mm−1. A 
final refinement on F2 with 2611 unique intensities and 138 
parameters converged at R(F2) = 0.0509 (R(F) = 0.0221) for 
2432 observed reflections with I > 2(I). 20 
Crystal data for 3b. C11H11I2N3, Mr = 439.03, monoclinic, P21/n, 
a = 6.9744(3), b = 26.4537(12), c = 7.2619(3) Å,  = 90.717(2)°, 
V = 1339.71(10) Å3, Z = 4, calcd = 2.177 g cm−3,  = 4.673 mm−1. 
A final refinement on F2 with 3018 unique intensities and 148 
parameters converged at R(F2) = 0.0601 (R(F) = 0.0281) for 25 
2908 observed reflections with I > 2(I). 
Crystal data for 4b. C17H17N3, Mr = 263.34, monoclinic, P21/c, a 
= 6.3843(5), b = 30.629(2), c = 7.1492(6) Å,  = 94.735(3)°, V = 
1393.22(18) Å3, Z = 4, calcd = 1.255 g cm−3,  = 0.076 mm−1. A 
final refinement on F2 with 3171 unique intensities and 183 30 
parameters converged at R(F2) = 0.1439 (R(F) = 0.0683) for 
2759 observed reflections with I > 2(I). 
Crystal data for 6j. C12H8I2N4, Mr = 462.02, orthorhombic, 
Pnab, a = 8.3852(3), b = 10.2090(3), c = 16.0643(5) Å, V = 
1375.18(8) Å3, Z = 4, calcd = 2.232 g cm−3,  = 4.561 mm−1. A 35 
final refinement on F2 with 1568 unique intensities and 83 
parameters converged at R(F2) = 0.0359 (R(F) = 0.017) for 
1406 observed reflections with I > 2(I). 
Crystal data for 8l. C7H4I2N2S1, Mr = 401.98, monoclinic, P21/n, 
a = 7.0510(2), b = 20.8154(6), c = 7.2666(2) Å,  = 100.688(2)°, 40 
V = 1048.01(5) Å3, Z = 4, calcd = 2.548 g cm−3,  = 6.150 mm−1. 
A final refinement on F2 with 2381 unique intensities and 109 
parameters converged at R(F2) = 0.0619 (R(F) = 0.0292) for 
2269 observed reflections with I > 2(I). 
Crystal data for 9m. C8H3ClI3N3, Mr = 557.28, monoclinic, 45 
P21/n, a = 11.8807(5), b = 7.3931(3), c = 14.3980(6) Å,  = 
92.696(2)°, V = 1263.25(9) Å3, Z = 4, calcd = 2.93 g cm−3,  = 
7.606 mm−1. A final refinement on F2 with 2882 unique 
intensities and 101 parameters converged at R(F2) = 0.0924 
(R(F) = 0.04) for 2561 observed reflections with I > 2(I). 50 
Crystal data for 7n. C8H6IN3, Mr = 271.06, monoclinic, P21/c, a 
= 7.1532(3), b = 14.7450(6), c = 8.1035(4) Å,  = 91.8830(10)°, 
V = 854.25(7) Å3, Z = 4, calcd = 2.108 g cm−3,  = 3.692 mm−1. A 
final refinement on F2 with 1957 unique intensities and 109 
parameters converged at R(F2) = 0.0504 (R(F) = 0.0207) for 55 
1824 observed reflections with I > 2(I). 
Crystal data for 8n. C8H5I2N3, Mr = 396.95, monoclinic, P21/c, a 
= 7.1322(2), b = 10.9173(3), c = 13.3983(4) Å,  = 99.7590(10)°, 
V = 1028.15(5) Å3, Z = 4, calcd = 2.564 g cm−3,  = 6.075 mm−1. 
A final refinement on F2 with 2357 unique intensities and 118 60 
parameters converged at R(F2) = 0.0445 (R(F) = 0.018) for 
2220 observed reflections with I > 2(I). 
Crystal data for 8o. C8H5I2N3, Mr = 396.95, monoclinic, P21/n, a 
= 6.8316(4), b = 13.4938(7), c = 12.1649(7) Å,  = 101.594(2)°, 
V = 1098.53(11) Å3, Z = 4, calcd = 2.4 g cm−3,  = 5.685 mm−1. A 65 
final refinement on F2 with 2499 unique intensities and 118 
parameters converged at R(F2) = 0.0675 (R(F) = 0.0291) for 
2315 observed reflections with I > 2(I). 
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N-(hetero)arylpyrazoles have been deproto-metallated using 1:1
LiTMP-(TMP)2Zn. The outcome of the reactions has been discussed in 
the light of DFT-calculated CH acidities (gas phase and THF solution).
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